globenewswire.com · Oct 7, 2025
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
LAS VEGAS, Oct. 07, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC: BDPT) today announced the commercial availability of MyndMed, a next-generation cognitive-support dietary supplement formulated to support memory, focus, mental clarity, and overall brain performance. Following rigorous testing with overwhelmingly positive results, the company is expanding distribution and scaling inventory to meet the expected high order volumes from November onward.
